Pregnancy and Childbirth in Women with Thalassemia Yesterday and Today
Pregnancy and Childbirth in Women with Thalassemia Yesterday and Today: a Multicentre Observational Study
Study Overview
Status
Status
Conditions
Conditions
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Cagliari, Italy, 09123
- UniversityCagliari, OspPed Microcitemico, Cagliari
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Transfusion dependent and nontransfusion- dependent thalassemia
- Pregnancy ended with the birth of a live or dead foetus
- Pregnancy ended in miscarriage or voluntary abortion
- Pregnancy in progress
Exclusion Criteria:
- Other types of anemia
- Pregnancy not initiated despite assisted fertilization practices
- Subjects unwilling to sign informed consent
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
number of pregnancies in women with beta thalassemia followed in Italian centres
Time Frame: 15 YEARS
|
To evaluate the number of pregnancies in women with beta thalassemia followed in Italian centres and how the increase in the average age of the thalassemia population impact on the number of new pregnancies over time
|
15 YEARS
|
|
number of pregnancies spontaneously
Time Frame: 15 YEARS
|
many pregnancies occurred spontaneously
|
15 YEARS
|
|
number of pregnancies after hormonal stimulation
Time Frame: 15 YEARS
|
number of pregnancies after hormonal stimulation
|
15 YEARS
|
|
likelihood of miscarriage
Time Frame: 15 YEARS
|
To evaluate the likelihood of miscarriage
|
15 YEARS
|
|
foetal death
Time Frame: 15 YEARS
|
To evaluate foetal death
|
15 YEARS
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- GRAV001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.